Treatment with cisplatin (5 mg·kg−1) and anti‐PD‐L1 inhibitors significantly reduced tumor size and weight, whereas VEGFR2 blockade did not (Fig. 6A–D). The gene discussed is KDR; the disease is neoplasm.